Adrenal Insufficiency Diagnosis

Adrenal insufficiency is a life-threatening endocrine disorder where the adrenal glands fail to produce sufficient cortisol. Mastering its diagnosis and management is critical because missing it can lead to fatal adrenal crisis, while recognizing it allows for simple, life-saving hormone replacement. You must understand the distinct pathways to hormone deficiency, the diagnostic tests that confirm it, and the nuanced treatment that keeps patients safe in daily life and during physiological stress.

Understanding the Cortisol Deficit: Primary vs. Secondary

The body's main stress hormone, cortisol, is produced by the adrenal cortex. Its secretion is controlled by a hormonal axis: the hypothalamus secretes corticotropin-releasing hormone (CRH), which stimulates the pituitary gland to release adrenocorticotropic hormone (ACTH), which in turn directs the adrenal glands to make cortisol. Failure at any point in this axis leads to adrenal insufficiency.

Primary adrenal insufficiency (Addison's disease) results from the direct destruction of the adrenal glands. The most common cause in the developed world is autoimmune adrenalitis. Because the adrenals are damaged, cortisol output is low. The pituitary gland senses this deficiency and responds by secreting very high levels of ACTH in a futile attempt to stimulate the adrenals. A classic clinical sign stemming from this high ACTH is hyperpigmentation—a tan-like darkening of skin creases, scars, and mucous membranes—because ACTH shares a precursor molecule with melanocyte-stimulating hormone (MSH).

Secondary adrenal insufficiency is far more common and is caused by pituitary dysfunction, leading to inadequate ACTH production. Without ACTH, the adrenals atrophy and stop producing sufficient cortisol. Key causes include long-term exogenous glucocorticoid use (which suppresses the axis), pituitary tumors, or surgery. Crucially, hyperpigmentation is absent because ACTH levels are low or normal, not elevated.

Confirming the Diagnosis: The Cosyntropin Stimulation Test

Clinical suspicion based on symptoms like fatigue, weight loss, nausea, and orthostatic hypotension must be confirmed biochemically. The cosyntropin stimulation test is the gold-standard diagnostic tool. Cosyntropin is a synthetic form of ACTH.

The procedure is straightforward: a baseline blood sample is drawn to measure serum cortisol. Then, 250 mcg of cosyntropin is administered via intramuscular or intravenous injection. A second cortisol level is measured 30 or 60 minutes later. A normal adrenal response is defined by a peak cortisol level typically above 18-20 µg/dL (500-550 nmol/L), though exact cut-offs vary by lab. A subnormal rise confirms adrenal insufficiency.

This test primarily assesses the adrenal gland's reserve. In primary insufficiency, the adrenals are destroyed and cannot respond, so cortisol levels remain flat. In long-standing secondary insufficiency, the adrenals are atrophic and also fail to respond. However, in very recent onset secondary insufficiency (e.g., within 2-4 weeks of pituitary damage), the adrenals may still respond to the synthetic ACTH, potentially giving a false-normal result. In such cases of high clinical suspicion, further testing (like an insulin tolerance test) may be needed.

Glucocorticoid Replacement: Mimicking Physiology

Once diagnosed, treatment involves replacing the missing cortisol. The goal is to mimic the body's natural physiologic rhythms, not to provide pharmacologic anti-inflammatory dosing. Hydrocortisone (identical to human cortisol) is the preferred replacement due to its short half-life, which allows for rhythmic dosing.

A standard regimen splits the total daily dose to reflect the normal diurnal cycle: two-thirds in the morning and one-third in the early afternoon (e.g., 15 mg at 7 AM, 5 mg at 2 PM). Other steroids like prednisone or dexamethasone are sometimes used but are less ideal because their longer action does not mimic natural rhythms as well and they carry a higher risk of side effects like osteoporosis. The principle is to use the lowest effective dose that alleviates symptoms and prevents crisis.

Stress Dosing: Preventing Adrenal Crisis

A patient on replacement therapy cannot mount an increased cortisol response to physical stress. Therefore, a core component of management is patient education on stress dosing. During illness, injury, or scheduled procedures, the body's cortisol requirement can increase 2 to 10 times normal.

A standard protocol for minor stress (e.g., fever > 38.5°C, mild flu, dental work) is to double or triple the daily oral hydrocortisone dose for 1-3 days. For major stress like major surgery, severe trauma, or significant illness with vomiting/diarrhea, immediate parenteral administration is required. In these scenarios, 100 mg of intravenous hydrocortisone is given, followed by a continuous infusion or repeated boluses every 6-8 hours until the stress resolves. Failure to provide this escalated coverage is the primary cause of preventable adrenal crisis, characterized by profound hypotension, shock, and death.

Common Pitfalls

1. Missing Subtle Presentations: In secondary adrenal insufficiency, the lack of hyperpigmentation and electrolyte disturbances (like hyperkalemia) can delay diagnosis. Attributing non-specific symptoms like chronic fatigue and malaise to depression or other causes without checking a morning cortisol is a common error.
2. Misinterpreting the Cosyntropin Test: Drawing the test in the afternoon or evening, when cortisol is physiologically low, can confound results. The test should ideally be performed in the morning. Furthermore, in patients with low albumin, total cortisol measurements may be misleadingly low; in such cases, a direct assay for free cortisol may be more accurate.
3. Overtreatment in Daily Management: Prescribing hydrocortisone at doses higher than 20-25 mg per day for simple replacement often leads to Cushingoid side effects—weight gain, osteoporosis, and diabetes—defeating the purpose of physiologic replacement. The dose must be individualized based on symptom control and well-being.
4. Neglecting Patient Education on Stress Dosing: Simply prescribing a daily dose without thorough, repeated instruction on sick-day rules is a critical failure in management. Every patient must have a written action plan and access to injectable hydrocortisone (e.g., Solu-Cortef) for emergencies, especially if they cannot keep oral medication down.

Summary

• Adrenal insufficiency is classified as primary (adrenal destruction with high ACTH and hyperpigmentation) or secondary (pituitary/hypothalamic dysfunction with low/normal ACTH and no hyperpigmentation).
• The definitive diagnostic test is the cosyntropin stimulation test, which assesses the adrenal gland's ability to produce cortisol in response to synthetic ACTH.
• Daily treatment with hydrocortisone aims to mimic the body's natural physiologic cortisol rhythm, using the lowest effective dose split between morning and early afternoon.
• Stress dosing protocols are non-negotiable and must be taught to all patients to prevent life-threatening adrenal crisis during illness, injury, or medical procedures.
• Management requires vigilance to avoid both undertreatment (leading to crisis) and overtreatment (leading to iatrogenic Cushing's syndrome).